| Jaclyn Lee Lantz, COTA/L | |
|
24 Kentallen Ln, Bella Vista, AR 72715-2903 | |
| (479) 531-3797 | |
| Not Available |
| Full Name | Jaclyn Lee Lantz |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 24 Kentallen Ln, Bella Vista, Arkansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770085854 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | OTR3841 (Arkansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jaclyn Lee Lantz, COTA/L 24 Kentallen Ln, Bella Vista, AR 72715-2903 Ph: (479) 531-3797 | Jaclyn Lee Lantz, COTA/L 24 Kentallen Ln, Bella Vista, AR 72715-2903 Ph: (479) 531-3797 |
News Archive
A study aimed at better understanding why some critically ill patients develop multidrug-resistant infections is underway by researchers at The University of Texas Health Science Center at Houston.
A committee of experts in Europe are calling for strong warnings to be placed on two classes of antidepressants, informing doctors and parents of the risk they could pose to children and adolescents.
In the largest randomized, double-blind, placebo controlled study to date on the effect of OnabotulinumtoxinA (as known as Botox) on depression, researchers found that more than half of subjects suffering from moderate to severe depression showed a substantial improvement (greater than or equal to 50% of baseline) in their depressive symptoms as measured by the MADRS scale.
SDI (Strategic Diagnostics Inc.), a provider of biotechnology-based products and services, and Fred Hutchinson Cancer Research Center (the Hutchinson Center) today jointly announced they will collaborate to discover biomarkers for use in the early detection of a variety of cancers.
Mylan Inc. today confirmed that the company has been sued by Takeda Pharmaceutical Company, Watson Pharmaceuticals and Andrx Labs in connection with the filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) for Pioglitazone Hydrochloride and Extended-release Metformin Hydrochloride tablets, 15 mg/1000 mg and 30 mg/1000 mg.
› Verified 8 days ago
Gloria Jean Pense, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 19 Billingsley Dr, Bella Vista, AR 72714 Phone: 479-220-0756 | |
Mr. Nolan W Barton, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 9 Cunningham Cor, Bella Vista, AR 72714 Phone: 479-751-7122 Fax: 479-751-7292 | |
Child's Play Therapy Services, Inc. Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 19 Billingsley Dr, Bella Vista, AR 72714 Phone: 479-220-0756 | |
Amanda Lynn Messmer, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3 Banbury Ln, Bella Vista, AR 72714 Phone: 479-420-4312 | |
Emily Millard, OTD, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2 Marlin Ln, Bella Vista, AR 72715 Phone: 417-389-4108 |